메뉴 건너뛰기




Volumn 128, Issue 2, 2014, Pages 195-201

Efficacy of intravenous levosimendan in patients with heart failure complicated by acute myocardial infarction

Author keywords

Acute myocardial infarction; Heart failure; Levosimendan; Prognosis

Indexed keywords

LEVOSIMENDAN; PLACEBO; CARDIOTONIC AGENT; HYDRAZONE DERIVATIVE; PYRIDAZINE DERIVATIVE; SIMENDAN;

EID: 84898671990     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000357864     Document Type: Article
Times cited : (18)

References (23)
  • 1
    • 25144443006 scopus 로고    scopus 로고
    • Reassessment of dobutamine, dopamine, and milrinone in the management of acute heart failure syndromes
    • DOI 10.1016/j.amjcard.2005.07.021, PII S0002914905011896
    • Bayram M, De Luca L, Massie MB, Gheorghiade M: Reassessment of dobutamine, dopamine, and milrinone in the management of acute heart failure syndromes. Am J Cardiol 2005; 96(6A):47G-58G. (Pubitemid 41338074)
    • (2005) American Journal of Cardiology , vol.96 , Issue.6 SUPPL.
    • Bayram, M.1    De Luca, L.2    Massie, M.B.3    Gheorghiade, M.4
  • 3
    • 0031736938 scopus 로고    scopus 로고
    • Cardiac responses to calcium sensitizers and isoproterenol in intact guinea pig hearts. Effects on cyclic AMP levels, protein phosphorylation, myoplasmic calcium concentration and left ventricular function
    • Kristof E, Szigeti G, Papp Z, Bodi A, Facsko A, Kovacs L, Papp JG, Kranias EG, Edes I: Cardiac responses to calcium sensitizers and isoproterenol in intact guinea pig hearts. Effects on cyclic AMP levels, protein phosphorylation, myoplasmic calcium concentration and left ventricular function. Ann N Y Acad Sci 1998; 853: 316-319.
    • (1998) Ann N y Acad Sci , vol.853 , pp. 316-319
    • Kristof, E.1    Szigeti, G.2    Papp, Z.3    Bodi, A.4    Facsko, A.5    Kovacs, L.6    Papp, J.G.7    Kranias, E.G.8    Edes, I.9
  • 5
    • 0037142946 scopus 로고    scopus 로고
    • Steering Committee and Investigators of the Levosimendan Infusion versus Dobutamine (LIDO) Study: Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial
    • Follath F, Cleland JG, Just H, Papp JG, Scholz H, Peuhkurinen K, Harjola VP, Mitrovic V, Abdalla M, Sandell EP, Lehtonen L; Steering Committee and Investigators of the Levosimendan Infusion versus Dobutamine (LIDO) Study: Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet 2002; 360: 196-202.
    • (2002) Lancet , vol.360 , pp. 196-202
    • Follath, F.1    Cleland, J.G.2    Just, H.3    Papp, J.G.4    Scholz, H.5    Peuhkurinen, K.6    Harjola, V.P.7    Mitrovic, V.8    Abdalla, M.9    Sandell, E.P.10    Lehtonen, L.11
  • 6
    • 0036764821 scopus 로고    scopus 로고
    • Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction: A randomized, placebo-controlled, double-blind study (RUSSLAN)
    • DOI 10.1053/euhj.2001.3158
    • Moiseyev VS, Poder P, Andrejevs N, Ruda MY, Golikov AP, Lazebnik LB, Kobalava ZD, Lehtonen LA, Laine T, Nieminen MS, Lie KI; RUSSLAN Study Investigators: Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN). Eur Heart J 2002; 23: 1422-1432. (Pubitemid 36285574)
    • (2002) European Heart Journal , vol.23 , Issue.18 , pp. 1422-1432
    • Moiseyev, V.S.1    Poder, P.2    Andrejevs, N.3    Ruda, M.Y.4    Golikov, A.P.5    Lazebnik, L.B.6    Kobalava, Z.D.7    Lehtonen, L.A.8    Laine, T.9    Nieminen, M.S.10    Lie, K.I.11
  • 8
    • 33750738272 scopus 로고    scopus 로고
    • REVIVE II: Multicenter placebocontrolled trial of levosimendan on clinical status in acutely decompensated heart failure
    • Presented at the Dallas, November 13-16
    • Packer M: REVIVE II: Multicenter placebocontrolled trial of levosimendan on clinical status in acutely decompensated heart failure. Presented at the American Heart Association Scientific Sessions, Dallas, November 13-16, 2005.
    • (2005) American Heart Association Scientific Sessions
    • Packer, M.1
  • 9
    • 20044379730 scopus 로고    scopus 로고
    • Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: The Task Force on Acute Heart Failure of the European Society of Cardiology
    • DOI 10.1093/eurheartj/ehi044
    • Nieminen MS, Bohm M, Cowie MR, Drexler H, Filippatos GS, Jondeau G, Hasin Y, Lopez-Sendon J, Mebazaa A, Metra M, Rhodes A, Swedberg K, Priori SG, Garcia MA, Blanc JJ, Budaj A, Cowie MR, Dean V, Deckers J, Burgos EF, Lekakis J, Lindahl B, Mazzotta G, Morais J, Oto A, Smiseth OA, Garcia MA, Dickstein K, Albuquerque A, Conthe P, Crespo-Leiro M, Ferrari R, Follath F, Gavazzi A, Janssens U, Komajda M, Morais J, Moreno R, Singer M, Singh S, Tendera M, Thygesen K; ESC Committe for Practice Guideline (CPG): Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 2005; 26: 384-416. (Pubitemid 40283098)
    • (2005) European Heart Journal , vol.26 , Issue.4 , pp. 384-416
    • Nieminen, M.S.1    Bohm, M.2    Cowie, M.R.3    Drexler, H.4    Filippatos, G.S.5    Jondeau, G.6    Hasin, Y.7    Lopez-Sendon, J.8    Mebazaa, A.9    Metra, M.10    Rhodes, A.11    Swedberg, K.12
  • 10
    • 53249090182 scopus 로고    scopus 로고
    • ESC Committee for Practice Guidelines (CPG): ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine ( ESICM)
    • Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Stromberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K; ESC Committee for Practice Guidelines (CPG): ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine ( ESICM). Eur Heart J 2008; 29: 2388-2442.
    • (2008) Eur Heart J , vol.29 , pp. 2388-2442
    • Dickstein, K.1    Cohen-Solal, A.2    Filippatos, G.3    McMurray, J.J.4    Ponikowski, P.5    Poole-Wilson, P.A.6    Stromberg, A.7    Van Veldhuisen, D.J.8    Atar, D.9    Hoes, A.W.10    Keren, A.11    Mebazaa, A.12    Nieminen, M.13    Priori, S.G.14    Swedberg, K.15
  • 11
    • 2942574937 scopus 로고    scopus 로고
    • The calcium sensitizer levosimendan improves the function of stunned myocardium after percutaneous transluminal coronary angioplasty in acute myocardial ischemia
    • DOI 10.1016/j.jacc.2004.02.052, PII S0735109704006886
    • Sonntag S, Sundberg S, Lehtonen LA, Kleber FX: The calcium sensitizer levosimendan improves the function of stunned myocardium after percutaneous transluminal coronary angioplasty in acute myocardial ischemia. J Am Coll Cardiol 2004; 43: 2177-2182. (Pubitemid 38757582)
    • (2004) Journal of the American College of Cardiology , vol.43 , Issue.12 , pp. 2177-2182
    • Sonntag, S.1    Sundberg, S.2    Lehtonen, L.3    Kleber, F.4
  • 12
    • 47749135245 scopus 로고    scopus 로고
    • Effects of levosimendan versus dobutamine on left ventricular diastolic function in patients with cardiogenic shock after primary angioplasty
    • DOI 10.1016/j.ijcard.2007.05.018, PII S0167527307010959
    • Dominguez-Rodriguez A, Samimi-Fard S, Garcia-Gonzalez MJ, Abreu-Gonzalez P: Effects of levosimendan versus dobutamine on left ventricular diastolic function in patients with cardiogenic shock after primary angioplasty. Int J Cardiol 2008; 128: 214-217. (Pubitemid 352033581)
    • (2008) International Journal of Cardiology , vol.128 , Issue.2 , pp. 214-217
    • Dominguez-Rodriguez, A.1    Samimi-Fard, S.2    Garcia-Gonzalez, M.J.3    Abreu-Gonzalez, P.4
  • 13
    • 44649131858 scopus 로고    scopus 로고
    • Effects of levosimendan versus dobutamine on long-term survival of patients with cardiogenic shock after primary coronary angioplasty
    • DOI 10.1016/j.ijcard.2007.04.143, PII S0167527307011989
    • Samimi-Fard S, Garcia-Gonzalez MJ, Dominguez-Rodriguez A, Abreu-Gonzalez P: Effects of levosimendan versus dobutamine on longterm survival of patients with cardiogenic shock after primary coronary angioplasty. Int J Cardiol 2008; 127: 284-287. (Pubitemid 351787809)
    • (2008) International Journal of Cardiology , vol.127 , Issue.2 , pp. 284-287
    • Samimi-Fard, S.1    Garcia-Gonzalez, M.J.2    Dominguez-Rodriguez, A.3    Abreu-Gonzalez, P.4
  • 15
    • 38649116373 scopus 로고    scopus 로고
    • Levosimendan in patients with acute myocardial ischaemia undergoing emergency surgical revascularization
    • DOI 10.1017/S0265021507002761, PII S0265021507002761
    • Lehmann A, Kiessling AH, Isgro F, Zeitler C, Thaler E, Boldt J: Levosimendan in patients with acute myocardial ischaemia undergoing emergency surgical revascularization. Eur J Anaesthesiol 2008; 25: 224-229. (Pubitemid 351170384)
    • (2008) European Journal of Anaesthesiology , vol.25 , Issue.3 , pp. 224-229
    • Lehmann, A.1    Kiessling, A.-H.2    Isgro, F.3    Zeitler, C.4    Thaler, E.5    Boldt, J.6
  • 16
    • 34548428716 scopus 로고    scopus 로고
    • Efficacy and safety of perioperative infusion of levosimendan in patients with compromised cardiac function undergoing open-heart surgery: Importance of early use
    • DOI 10.1016/j.ejcts.2007.07.010, PII S1010794007006240
    • Tasouli A, Papadopoulos K, Antoniou T, Kriaras I, Stavridis G, Degiannis D, Geroulanos S: Efficacy and safety of perioperative infusion of levosimendan in patients with compromised cardiac function undergoing openheart surgery: importance of early use. Eur J Cardiothorac Surg 2007; 32: 629-633. (Pubitemid 47362731)
    • (2007) European Journal of Cardio-thoracic Surgery , vol.32 , Issue.4 , pp. 629-633
    • Tasouli, A.1    Papadopoulos, K.2    Antoniou, T.3    Kriaras, I.4    Stavridis, G.5    Degiannis, D.6    Geroulanos, S.7
  • 17
    • 35448971466 scopus 로고    scopus 로고
    • Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction: Universal definition of myocardial infarction
    • Thygesen K, Alpert JS, White HD; Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction: Universal definition of myocardial infarction. Eur Heart J 2007; 28: 2525-2538.
    • (2007) Eur Heart J , vol.28 , pp. 2525-2538
    • Thygesen, K.1    Alpert, J.S.2    White, H.D.3
  • 19
    • 79955760903 scopus 로고    scopus 로고
    • 2011 Writing Group Members; ACCF/AHA Task Force Members: 2011 ACCF/AHA Focused Update incorporated into the ACC/AHA 2007 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines
    • Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr, Chavey WE 2nd, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Wenger NK, Wright RS, Smith SC Jr; 2011 Writing Group Members; ACCF/AHA Task Force Members: 2011 ACCF/AHA Focused Update incorporated into the ACC/AHA 2007 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 2011; 123: e426-e579.
    • (2011) Circulation , vol.123
    • Anderson, J.L.1    Adams, C.D.2    Antman, E.M.3    Bridges, C.R.4    Califf, R.M.5    Casey Jr., D.E.6    Chavey, I.I.W.E.7    Fesmire, F.M.8    Hochman, J.S.9    Levin, T.N.10    Lincoff, A.M.11    Peterson, E.D.12    Theroux, P.13    Wenger, N.K.14    Wright, R.S.15    Smith Jr., S.C.16
  • 20
    • 2942556913 scopus 로고    scopus 로고
    • Clinical trials update and cumulative meta-analyses from the American College of Cardiology: WATCH, SCD-HeFT, DINAMIT, CASINO, INSPIRE, STRATUS-US, RIO-LIPIDS and cardiac resynchronisation therapy in heart failure
    • DOI 10.1016/j.ejheart.2004.04.014, PII S1388984204001503
    • Cleland JG, Ghosh J, Freemantle N, Kaye GC, Nasir M, Clark AL, Coletta AP: Clinical trials update and cumulative meta-analyses from the American College of Cardiology: WATCH, SCD-HeFT, DINAMIT, CASINO, INSPIRE, STRATUS-US, RIO-Lipids and cardiac resynchronisation therapy in heart failure. Eur J Heart Fail 2004; 6: 501-508. (Pubitemid 38746595)
    • (2004) European Journal of Heart Failure , vol.6 , Issue.4 , pp. 501-508
    • Cleland, J.G.F.1    Ghosh, J.2    Freemantle, N.3    Kaye, G.C.4    Nasir, M.5    Clark, A.L.6    Coletta, A.P.7
  • 23
    • 84877107554 scopus 로고    scopus 로고
    • Levosimendan in acute heart failure following primary percutaneous coronary intervention-treated acute ST-elevation myocardial infarction. Results from the LEAF trial: A randomized, placebocontrolled study
    • Husebye T, Eritsland J, Muller C, Sandvik L, Arnesen H, Seljeflot I, Mangschau A, Bjornerheim R, Andersen GO: Levosimendan in acute heart failure following primary percutaneous coronary intervention-treated acute ST-elevation myocardial infarction. Results from the LEAF trial: a randomized, placebocontrolled study. Eur J Heart Fail 2013; 15: 565-572.
    • (2013) Eur J Heart Fail , vol.15 , pp. 565-572
    • Husebye, T.1    Eritsland, J.2    Muller, C.3    Sandvik, L.4    Arnesen, H.5    Seljeflot, I.6    Mangschau, A.7    Bjornerheim, R.8    Andersen, G.O.9


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.